MK
Manjeet Kaur
About Manjeet Kaur
Data last updated:
Manjeet Kaur is a Director at Sorbax Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Sorbax Pharmaceuticals Private Limited reported revenue of ₹6.71 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Apr 2024 | 2020 | ₹6.71 Cr (FY 2025) | Active |
Board colleagues of Manjeet Kaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dheeraj Gangadhara Shetty | 09090341 | Sorbax Pharmaceuticals Private Limited | Director |
| Kota Suresh Prabhu | 08920717 | Sorbax Pharmaceuticals Private Limited | Director |
| Lalan Kumar Singh | 08920716 | Sorbax Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manjeet Kaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manjeet Kaur
Manjeet Kaur currently holds 1 directorship: Sorbax Pharmaceuticals Private Limited (Director, since 26 Apr 2024, revenue ₹6.71 Cr (FY 2025)).
Manjeet Kaur was first appointed on 26 Apr 2024 as Director at Sorbax Pharmaceuticals Private Limited.
The current boards of Manjeet Kaur's companies include Dheeraj Gangadhara Shetty (Sorbax Pharmaceuticals Private Limited), Kota Suresh Prabhu (Sorbax Pharmaceuticals Private Limited), Lalan Kumar Singh (Sorbax Pharmaceuticals Private Limited).